References
- Baxter Healthcare. FloSeal [haemostatic matrix] instructions for use, 0706463. CA: Baxter Healthcare Corporation.
- Law LW, Chor CM, Leung TY. 2010. Use of hemostatic gel in postpartum hemorrhage due to placenta previa. Obstetrics and Gynecology 116(Suppl 2):528–530.
- McNanley AR, Duecy EE. 2009. Floseal for treatment of retropubic bleeding during placement of tension-free vaginal tape. Journal of Pelvic Medicine and Surgery 15:25–27.
- Moriarty KT, Premila S, Bulmer PJ. 2008. Use of Floseal haemostatic gel in massive obstetric haemorrhage: a case report. British Journal of Obstetrics and Gynaecology 115:793–795.
- Nasso G, Piancone F, Bonifazi R . 2009. Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery. Annals of Thoracic Surgery 88:1520–1526.
- Renkens KL, Payner T, Leipzig TJ . 2001. A multicentre prospective randomised trial evaluating a new haemostatic agent for spinal surgery. Spine 26: 1645–1650.
- Ritcher F, Schnorr D, Deger S . 2003. Improvement of haemostasis in open and laparoscopically performed partial nephrectomy using a gelatine matrix – thrombin sealant (Floseal). Urology 61:73–77.
- Thomas PJ, Tawfic SN. 2009. Eosinophil-rich inflammatory response to FloSeal hemostatic matrix presenting as postoperative pelvic pain. American Journal of Obstetrics and Gynecology 200:e10–e11.
- Whiteside JL, Asif RB, Novello RJ. 2010. Fibrin sealant for management of complicated obstetric lacerations. Obstetrics and Gynecology 115(2 Part 2):403–404.